Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbon Nanoparticles for Central Neck Dissection in PTC
NCT02724176Completed
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Jan 2012
- Primary completion
- Jan 2016
- Modality
- Nanoparticles
01
Overview
Randomised, open-label trial of carbon nanoparticles in papillary thyroid cancer (PTC) (2 arms), sponsored by Peking University Cancer Hospital & Institute. Primary endpoints: Lymph node metastatic rate at 1 year, Total dissected lymph nodes less than 5mm at 1 year and 1 more. Started Jan 2012; status: completed.
02
Drugs
carbon nanoparticles
03
Conditions
papillary thyroid cancer (PTC)
Beyond the preview
Go deeper on NCT02724176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02724176.